A single-center, phase 1/2a trial of hESC-derived mesenchymal stem cells (MR-MC-01) for safety and efficacy in interstitial cystitis patients

Authors	Kyung Yoon Soo, Hong Ki-Sung, Chung Hyung-Min, Hyun Shin Jung, Choo Myung-Soo, Kim Eun-Young, Shin Jeong Min, Kang Ah Reum, Seo Jin Won, Park Juhyun, Park Se-Pill
Journal	Stem Cells Translational Medicine
Publication Date	2025-05-19
DOI	10.1093/stcltm/szaf018